Potential side effects can vary depending on the treatment plan and formulation prescribed
Strategic Investment for Future Growth Srinivas Sadu, Executive Chairman of Gland Pharma, commented on the expansion: "Our investments in global CDMO expansion, capacity enhancement in high-end modalities and complex injectables pipeline continue to strengthen our foundation and support sustainable growth and long-term value for all stakeholders." This capacity expansion aligns with Gland Pharma's strategy to diversify its product portfolio and tap into emerging pharmaceutical trends
SGLT-2 inhibitors are superior to GLP-1RA in reducing the risk of HHF and renal events
This guide covers the two states in which you'll encounter peptides lyophilized (freeze-dried powder) and reconstituted (dissolved in solution) and the specific storage requirements for each
In the future, leveraging the coordination between the metal sites on the surface of UMIOs and catechol, Semaglutide can be co-loaded onto their surface to construct MRI-visible anti-fibrotic nanomedicines, thereby achieving single-injection, synchronous imaging-therapy for precise liver management
You won't be disappointed